Brady’s FreezerBondz™ Labels Facilitate Virus Research
News Dec 16, 2009
In Cardiff University’s Medical Microbiology Department, frozen cell, virus and plasmid samples are labelled using Brady’s specially developed FreezerBondz™ ID system which withstands long-term low-temperature storage.
Dr Carole Rickards, Laboratory Manager for Infection, Immunity & Biochemistry in the Medical Microbiology Department of Cardiff University, explains the significance of the group’s work: “One of our main projects involves looking at how herpes viruses such as Human Cytomegalovirus (HCMV) manage to evade the immune system and persist in the body following a primary infection.”
“HCMV is the major viral cause of congenital malformation, is associated with life-threatening disease in immunocompromised individuals and is a causative agent of hepatitis, colitis, post-transplantation arteriosclerosis and infectious mononucleosis,” Dr. Rickards continued.
“One of the ways we study this important pathogen is by putting HCMV genes into Adenovirus. Our vast banks of over 800 cell lines stored in liquid nitrogen, as well as frozen plasmid and virus samples at –20 ºC and –70 ºC, together form a vital resource for research. We use Brady’s FreezerBondz™ labels, printed using the BBP11 thermal transfer printer, to ensure that the data for each sample remains legible and intact during long-term storage at low temperatures.”
The BBP11 thermal transfer printer from Brady, the world leader in Identification Solutions, provides fast, economical 300 dpi printing on a wide range of high performance label materials. FreezerBondz™ labels are legible and durable, and can be applied to frozen surfaces including glass and polypropylene stored in liquid nitrogen. Brady’s IdentiLab™ labelling software supports database import and 2D or linear barcoding, while easy-to-use wizards help create new files and templates.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE